BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21677340)

  • 1. Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.
    Bahde R; Hölzen JP; Wolters HH; Schmidt HH; Bock CT; Lügering A; Spieker T; Senninger N; Brockmann JG
    Ann Hepatol; 2011; 10(3):355-60. PubMed ID: 21677340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
    Lerut JP; Donataccio M; Ciccarelli O; Roggen F; Jamart J; Laterre PF; Cornu C; Mazza D; Hanique G; Rahier J; Geubel AP; Otte JB
    J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.
    Hwang S; Lee SG; Park KM; Kim KH; Ahn CS; Oh HB; Moon DB; Ha TY; Lim YS; Jung DH
    Liver Transpl; 2006 Jun; 12(6):993-7. PubMed ID: 16721765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis.
    Reynès M; Zignego L; Samuel D; Fabiani B; Gugenheim J; Tricottet V; Brechot C; Bismuth H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2424-5. PubMed ID: 2652792
    [No Abstract]   [Full Text] [Related]  

  • 9. Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study.
    ten Kate FJ; Schalm SW; Willemse PJ; Blok AP; Heijtink RA; Terpstra OT
    J Hepatol; 1992 Mar; 14(2-3):168-75. PubMed ID: 1500681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of hepatitis delta virus reinfection and disease in liver transplantation.
    Ottobrelli A; Marzano A; Smedile A; Recchia S; Salizzoni M; Cornu C; Lamy ME; Otte JB; De Hemptinne B; Geubel A
    Gastroenterology; 1991 Dec; 101(6):1649-55. PubMed ID: 1955130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects.
    David E; Rahier J; Pucci A; Camby P; Scevens M; Salizzoni M; Otte JB; Galmarini D; Marinucci G; Ottobrelli A
    Gastroenterology; 1993 Apr; 104(4):1122-8. PubMed ID: 8462801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
    J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus.
    Adil B; Fatih O; Volkan I; Bora B; Veysel E; Koray K; Cemalettin K; Burak I; Sezai Y
    Transplant Proc; 2016; 48(6):2119-23. PubMed ID: 27569956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
    Cholongitas E; Papatheodoridis GV; Burroughs AK
    J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.
    Hopf U; Neuhaus P; Lobeck H; König V; Küther S; Bauditz J; Bechstein WO; Blumhardt G; Steffen R; Neuhaus R
    J Hepatol; 1991 Nov; 13(3):339-46. PubMed ID: 1808226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.